Crovalimab Filed In Japan As More Phase III Results Released At EHA

Potential Lower Dosing Time Benefit

 
• By Lisa Takagi
  
Crovalimab is now under the review for approval in both China and Japan
Crovalimab is now under the review for approval in both China and Japan • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category